$NEO
NEOGENOMICS INC Stock $neo

$neo Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000156459018005479 Filed on March 13, 2018

Income Statement

Concept	2017 Q4	2017 Q3	2017
Revenue	$67.79M	$63.05M	$258.6M
YoY Change	12.07%	3.77%	5.95%
Cost Of Revenue	$34.70M	$34.24M	$138.3M
YoY Change	4.52%	2.47%	3.43%
Gross Profit	$26.76M	$24.90M	$102.0M
YoY Change	-1.81%	-8.96%	3.93%
Gross Profit Margin	39.48%	39.48%	39.42%
Selling, General & Admin	$22.50M	$24.63M	$94.36M
YoY Change	61.87%	-1.41%	7.43%
% of Gross Profit	84.07%	98.94%	92.55%
Research & Development	$600.0K	$1.270M	$3.636M
YoY Change	-33.33%	31.33%	-21.79%
% of Gross Profit	2.24%	5.1%	3.57%
Depreciation & Amortization	$5.660M	$5.580M	$15.60M
YoY Change	-8.86%	-7.46%	-2.14%
% of Gross Profit	21.15%	22.41%	15.3%
Operating Expenses	$23.00M	$26.96M	$99.05M
YoY Change	54.36%	3.89%	3.24%
Operating Profit	$3.762M	-$2.064M	$2.902M
YoY Change	-69.55%	-247.96%	34.66%
Interest Expense	-$1.400M	-$1.400M	$5.540M
YoY Change	-74.55%	-6.67%	-155.4%
% of Operating Profit	-37.21%		190.9%
Other Income/Expense, Net	$0.00	$0.00	-$12.00K
YoY Change
Pretax Income	$2.300M	-$3.462M	-$2.650M
YoY Change	-126.14%	4642.47%	-66.21%
Income Tax	$800.0K	$802.0K	-$2.254M
% Of Pretax Income	34.78%
Net Earnings	$4.549M	-$4.264M	-$396.0K
YoY Change	-173.09%	6264.18%	-93.55%
Net Earnings / Revenue	6.71%	-6.76%	-0.15%
Basic Earnings Per Share
Diluted Earnings Per Share	$56.18K	-$54.02K	-$5.038K
COMMON SHARES
Basic Shares Outstanding	86.68M shares	79.62M shares	79.43M shares
Diluted Shares Outstanding	88.61M shares	79.62M shares	79.43M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2017
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.80M	$12.20M	$12.80M
YoY Change	2.4%	-57.79%	2.4%
Cash & Equivalents	$12.82M	$12.21M	$12.80M
Short-Term Investments
Other Short-Term Assets	$1.001M	$4.700M	$5.200M
YoY Change	-77.76%	-37.33%	15.56%
Inventory	$7.474M	$6.100M	$7.500M
Prepaid Expenses	$4.152M
Receivables	$60.43M	$62.70M	$60.40M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$85.88M	$85.70M	$85.90M
YoY Change	8.94%	-7.41%	9.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.50M	$34.50M	$36.50M
YoY Change	7.25%	0.97%	7.35%
Goodwill	$147.0M
YoY Change	0.0%
Intangibles	$74.17M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$891.0K	$300.0K	$900.0K
YoY Change	412.07%	72.41%	350.0%
Total Long-Term Assets	$258.6M	$258.2M	$258.6M
YoY Change	0.11%	-1.78%	0.12%
TOTAL ASSETS
Total Short-Term Assets	$85.88M	$85.70M	$85.90M
Total Long-Term Assets	$258.6M	$258.2M	$258.6M
Total Assets	$344.5M	$343.9M	$344.5M
YoY Change	2.18%	-3.24%	2.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.45M	$14.80M	$10.50M
YoY Change	-37.73%	5.84%	-37.5%
Accrued Expenses	$17.00M	$16.80M	$15.60M
YoY Change	34.92%	6.33%	23.81%
Deferred Revenue	$1.406M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.750M	$8.500M	$9.000M
YoY Change	0.0%	1215.79%	3.45%
Total Short-Term Liabilities	$36.47M	$40.10M	$36.50M
YoY Change	-4.31%	13.3%	-4.2%
LONG-TERM LIABILITIES
Long-Term Debt	$91.13M	$96.60M	$96.40M
YoY Change	-0.89%	85.08%	-1.03%
Other Long-Term Liabilities	$283.0K		$300.0K
YoY Change
Total Long-Term Liabilities	$103.4M	$96.60M	$96.70M
YoY Change	-8.01%	30.64%	-0.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$36.47M	$40.10M	$36.50M
Total Long-Term Liabilities	$103.4M	$96.60M	$96.70M
Total Liabilities	$139.9M	$144.2M	$139.9M
YoY Change	-7.07%	31.89%	-7.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$58.42M
YoY Change	11.36%
Common Stock	$230.0M
YoY Change	6.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$172.0M	$199.7M	$204.6M
YoY Change
Total Liabilities & Shareholders Equity	$344.5M	$343.9M	$344.5M
YoY Change	2.18%	-3.24%	2.2%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017
OPERATING ACTIVITIES
Net Income	$4.549M	-$4.264M	-$396.0K
YoY Change	-173.09%	6264.18%	-93.55%
Depreciation, Depletion And Amortization	$5.660M	$5.580M	$15.60M
YoY Change	-8.86%	-7.46%	-2.14%
Cash From Operating Activities	$5.760M	$7.440M	$18.04M
YoY Change	-2500.0%	-22.66%	-16.03%
INVESTING ACTIVITIES
Capital Expenditures	-$3.520M	-$2.310M	$13.69M
YoY Change	59.28%	21.58%	81.66%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$0.00		$0.00
YoY Change	-100.0%		-100.0%
Cash From Investing Activities	-$3.520M	-$2.310M	-$13.69M
YoY Change	200.85%	21.58%	110.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.586M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.670M	-3.860M	-$4.095M
YoY Change	-88.86%	565.52%	-84.17%
NET CHANGE
Cash From Operating Activities	5.760M	7.440M	$18.04M
Cash From Investing Activities	-3.520M	-2.310M	-$13.69M
Cash From Financing Activities	-1.670M	-3.860M	-$4.095M
Net Change In Cash	570.0K	1.270M	$296.0K
YoY Change	-103.48%	-82.21%	-102.72%
FREE CASH FLOW
Cash From Operating Activities	$5.760M	$7.440M	$18.04M
Capital Expenditures	-$3.520M	-$2.310M	$13.69M
Free Cash Flow	$9.280M	$9.750M	$4.347M
YoY Change	371.07%	-15.36%	-68.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	174000
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16782000
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80507094
CY2017Q2	dei	Entity Public Float EntityPublicFloat	653100000
CY2017	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-1058000
CY2017	neo	Amortization Of Preferred Stock Beneficial Conversion Feature AmortizationOfPreferredStockBeneficialConversionFeature	6902000
CY2015	us-gaap	Operating Expenses OperatingExpenses	49391000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-5635000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4489000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11393000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	163723000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	40530000
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-30397000
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80462574
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12821000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60427000
CY2017Q4	us-gaap	Inventory Net InventoryNet	7474000
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4241000
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4535000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	84963000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36504000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	74165000
CY2017Q4	us-gaap	Goodwill Goodwill	147019000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	689000
CY2017Q4	us-gaap	Assets Assets	343340000
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10450000
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9482000
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8351000
CY2017Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	6144000
CY2016Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4247000
CY2017Q4	neo	Short Term Portion Of Car Loans ShortTermPortionOfCarLoans	49000
CY2016Q4	neo	Short Term Portion Of Car Loans ShortTermPortionOfCarLoans	92000
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	5190000
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	4891000
CY2017Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	3750000
CY2016Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	3750000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	35065000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38113000
CY2017Q4	neo	Long Term Portion Of Car Loans LongTermPortionOfCarLoans	20000
CY2016Q4	neo	Long Term Portion Of Car Loans LongTermPortionOfCarLoans	110000
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5283000
CY2017Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12525000
CY2016Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	50000000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	55512000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	78825000
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34036000
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	77064000
CY2016Q4	us-gaap	Goodwill Goodwill	147019000
CY2016Q4	us-gaap	Assets Assets	337118000
CY2016Q4	us-gaap	Inventory Net InventoryNet	6253000
CY2017Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	6864000
CY2017	neo	Pharma Services PharmaServices	26863000
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	14973000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-846000
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77542000
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60526000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	2574000
CY2015	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	40000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3636000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2635000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	2324000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7424000
CY2016	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	18011000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1954000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1701000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-5723000
CY2015	neo	Amortization Of Preferred Stock Beneficial Conversion Feature AmortizationOfPreferredStockBeneficialConversionFeature	82000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3481000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-2535000
CY2017	us-gaap	Operating Expenses OperatingExpenses	117992000
CY2017	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24543000
CY2016	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23910000
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5378000
CY2017Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	66616000
CY2016Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	70149000
CY2017	us-gaap	Interest And Debt Expense InterestAndDebtExpense	5540000
CY2015	neo	Pharma Services PharmaServices	1207000
CY2017	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	258611000
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	244083000
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	99802000
CY2017	us-gaap	Cost Of Services CostOfServices	138295000
CY2016	us-gaap	Cost Of Services CostOfServices	133704000
CY2015	us-gaap	Cost Of Services CostOfServices	56046000
CY2017	us-gaap	Gross Profit GrossProfit	120316000
CY2015	us-gaap	Gross Profit GrossProfit	43756000
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	88755000
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	75782000
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4649000
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4198000
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11562000
CY2016	us-gaap	Operating Expenses OperatingExpenses	107805000
CY2016	us-gaap	Interest And Debt Expense InterestAndDebtExpense	9998000
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-265000
CY2017	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	3645000
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	216104000
CY2016Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	21799000
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6307000
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	24516000
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	112409000
CY2017Q4	us-gaap	Liabilities Liabilities	137807000
CY2016Q4	us-gaap	Liabilities Liabilities	150522000
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	32615000
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	22873000
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	80000
CY2016	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.39
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	79000
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	230030000
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.04
CY2017	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.14
CY2016	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.39
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	274000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57466000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52460000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	172918000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	343340000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	337118000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13700000
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13699000
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27102000
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80462574
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78571158
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78571158
CY2016Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	50000000
CY2017Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	6864000
CY2016Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	6600000
CY2016Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	6600000
CY2017	neo	Clinical Services Revenue ClinicalServicesRevenue	231748000
CY2016	neo	Clinical Services Revenue ClinicalServicesRevenue	222015000
CY2015	neo	Clinical Services Revenue ClinicalServicesRevenue	98595000
CY2016	neo	Pharma Services PharmaServices	22068000
CY2016	us-gaap	Gross Profit GrossProfit	110379000
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33631000
CY2016	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3464000
CY2015	us-gaap	Interest And Debt Expense InterestAndDebtExpense	854000
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000000
CY2016	neo	Amortization Of Preferred Stock Beneficial Conversion Feature AmortizationOfPreferredStockBeneficialConversionFeature	6663000
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2657000
CY2017	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.14
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.04
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79426000
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79426000
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77542000
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	44000
CY2017	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	230000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	274000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-572000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	148000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	267000
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3299000
CY2016	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2103000
CY2015	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	5903000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	18037000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	209510000
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5723000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2535000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	60405000
CY2015	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	369000
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	714000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	118000
CY2015	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	102510000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	44720000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	40000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	82000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	590000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2889000
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	736000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	21477000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	6393000
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	44000
CY2016	neo	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature From Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureFromRedeemablePreferredStock	24596000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	18011000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	6663000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	460000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4978000
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	844000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	218000
CY2017	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	230000
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4095000
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1960000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	3645000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	6097000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	96000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6345000
CY2015	neo	Impact Of Tax Valuation Allowance ImpactOfTaxValuationAllowance	2066000
CY2017	us-gaap	Depreciation Depreciation	15596000
CY2016	us-gaap	Depreciation Depreciation	15937000
CY2015	us-gaap	Depreciation Depreciation	6730000
CY2017	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	253000
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6995000
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7272000
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	412000
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1099000
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	440000
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3497000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	6441000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	5438000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	3479000
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	18649000
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11856000
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2318000
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24243000
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18425000
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3215000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1423000
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1145000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	896000
CY2017	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	29000
CY2016	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	44000
CY2015	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-11000
CY2017	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	310000
CY2016	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-354000
CY2015	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3748000
CY2017	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-4544000
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-1035000
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	72940000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13690000
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7536000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2215000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13690000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-6501000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-75155000
CY2017	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2496000
CY2016	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	12856000
CY2017	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	5424000
CY2015	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	10002000
CY2016	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	5293000
CY2015	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	4115000
CY2016	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	75000000
CY2015	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	55022000
CY2016	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	55000000
CY2017	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3753000
CY2016	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	55000000
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2202000
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3351000
CY2017	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2586000
CY2016	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3768000
CY2015	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	935000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-4095000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-25871000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	58493000
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	44000
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	296000
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-10895000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-10269000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23420000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33689000
CY2017	us-gaap	Interest Paid InterestPaid	5155000
CY2016	us-gaap	Interest Paid InterestPaid	5423000
CY2015	us-gaap	Interest Paid InterestPaid	911000
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	284000
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	290000
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	25000
CY2017	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	5728000
CY2016	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	6057000
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	4813000
CY2015	neo	Fair Value Of Common Stock Issued To Fund Acquisition FairValueOfCommonStockIssuedToFundAcquisition	102510000
CY2015	neo	Fair Value Of Preferred Stock Issued To Fund Acquisition FairValueOfPreferredStockIssuedToFundAcquisition	73200000
CY2017	neo	Fair Value Of Restricted Stock Issued To Fund Purchase Of Customer List FairValueOfRestrictedStockIssuedToFundPurchaseOfCustomerList	4095000
CY2017	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0
CY2016	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0
CY2015	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	890000
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America. These principles require management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the consolidated financial statements. Actual results and outcomes may differ from management’s estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these consolidated financial statements include, but are not limited to, those related to revenues, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets and intangible assets, income taxes and valuation allowances, stock-based compensation and impairment analysis of goodwill. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the consolidated financial statements prospectively from the date of the change in estimate.</p></div>
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Concentrations of Credit Risk</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to revenue and accounts receivable are primarily limited to certain clients and geographies to which the Company provides a significant volume of its services, and to specific payers of our services such as Medicare and individual insurance companies. The Company’s client base consists of a large number of geographically dispersed clients diversified across various customer types. For the years ended December 31, 2017, 2016 and 2015, no clients accounted for more than 5% of revenue.  Due to the acquisition of Clarient, our concentration of revenue shifted from Florida to California.  For the years ended December 31, 2017, 2016 and 2015, revenue derived from the State of California accounted for 21.1%, 24.0% and 20.2%, respectively, of total revenue.  For the years ended December 31, 2017, 2016 and 2015, revenue derived from the State of Florida accounted for 13.9%, 15.0% and 20.5%, respectively, of total revenue.</p></div>
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2017	neo	Percentage Of Consolidated Assets Net Revenues And Net Income Reported By Reportable Operating Segment PercentageOfConsolidatedAssetsNetRevenuesAndNetIncomeReportedByReportableOperatingSegment	1.00
CY2016	neo	Percentage Of Consolidated Assets Net Revenues And Net Income Reported By Reportable Operating Segment PercentageOfConsolidatedAssetsNetRevenuesAndNetIncomeReportedByReportableOperatingSegment	1.00
CY2015	neo	Percentage Of Consolidated Assets Net Revenues And Net Income Reported By Reportable Operating Segment PercentageOfConsolidatedAssetsNetRevenuesAndNetIncomeReportedByReportableOperatingSegment	1.00
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13929000
CY2015Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2017Q1	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1 NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	6400000
CY2017	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Income NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetIncome	0
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0
CY2016Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	9481000
CY2017Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	10473000
CY2016Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	10470000
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2017	neo	Milestone Payments MilestonePayments	0
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	88094000
CY2017	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	360174000
CY2016	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	493678000
CY2015	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	225057000
CY2017	neo	Contractual Adjustments And Discounts ContractualAdjustmentsAndDiscounts	101563000
CY2016	neo	Contractual Adjustments And Discounts ContractualAdjustmentsAndDiscounts	249595000
CY2015	neo	Contractual Adjustments And Discounts ContractualAdjustmentsAndDiscounts	125255000
CY2017	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	10800000
CY2016	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	10300000
CY2015	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	3600000
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4759000
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4180000
CY2017	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	18648000
CY2016	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2916000
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1739000
CY2017	neo	Number Of Clients Accounting For More Than Five Percent Of Revenue NumberOfClientsAccountingForMoreThanFivePercentOfRevenue	0
CY2016	neo	Number Of Clients Accounting For More Than Five Percent Of Revenue NumberOfClientsAccountingForMoreThanFivePercentOfRevenue	0
CY2015	neo	Number Of Clients Accounting For More Than Five Percent Of Revenue NumberOfClientsAccountingForMoreThanFivePercentOfRevenue	0
CY2017Q4	neo	Property Plant And Equipment Minimum Cost PropertyPlantAndEquipmentMinimumCost	1000
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2016	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	3500000
CY2017	neo	Minimum Threshold Percentage Of Voting Securities On Acquisition For Deemed Liquidation Event MinimumThresholdPercentageOfVotingSecuritiesOnAcquisitionForDeemedLiquidationEvent	0.50
CY2017	neo	Maximum Voting Power Percentage After Consolidation Merger Or Reorganization For Deemed Liquidation Event MaximumVotingPowerPercentageAfterConsolidationMergerOrReorganizationForDeemedLiquidationEvent	0.50
CY2017	neo	Preferred Stock Conversion Trading Price Per Share PreferredStockConversionTradingPricePerShare	8.00
CY2017	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	conversion (Written Call Option) on the underlying shares if after three years the stock trades at $8.00 for thirty trading days, and (v) conversion (Contingent Forward) on the underlying shares automatically at the ten year anniversary of the issue date.
CY2017	neo	Accretion Expense Recognized Period AccretionExpenseRecognizedPeriod	P3Y
CY2017	neo	Largest Amount Of Tax Benefit LargestAmountOfTaxBenefit	Greater than 50%
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	77034000
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	61138000
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15596000
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15937000
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6730000
CY2017Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	18033000
CY2016Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	19951000
CY2017Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	7560000
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	88912000
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8384000
CY2016Q4	neo	Finite Lived Intangible Assets Impairment FiniteLivedIntangibleAssetsImpairment	3464000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5685000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5680000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5671000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5671000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5671000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	45787000
CY2017Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	10542000
CY2016Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	10471000
CY2017Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	107192000
CY2016Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	108371000
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1768000
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2202000
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	8989000
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	8733000
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	96435000
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	97436000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3750000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5625000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5625000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	81650000
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	96650000
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3750000
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	91132000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5650000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	4056000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	1531000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	11237000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	695000
CY2017Q4	neo	Capital Lease Obligations And Car Loans Current CapitalLeaseObligationsAndCarLoansCurrent	5239000
CY2017Q4	neo	Capital Lease Obligations And Car Loans Noncurrent CapitalLeaseObligationsAndCarLoansNoncurrent	5303000
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	9400000
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	9681000
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	7156000
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	81650000
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	107887000
CY2017	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	695000
CY2017Q4	neo	Volume Weighted Average Price Per Share VolumeWeightedAveragePricePerShare	8.00
CY2016	neo	Preferred Stock Convertible Threshold Consecutive Trading Period PreferredStockConvertibleThresholdConsecutiveTradingPeriod	P30D
CY2017	neo	Temporary Equity Redemption Description TemporaryEquityRedemptionDescription	At any time, and from time to time, we may redeem for cash all, or any portion of, the outstanding Series A Preferred Stock at a price per share equal to the then effective Liquidation Preference, provided the aggregate amount redeemed at such time is not less than (a) from the Original Issue Date until the fourth anniversary thereof, $10.0 million and (b) thereafter, $5.0 million, and in each case only in $1.0 million increments above such amounts.
CY2017	neo	Temporary Equity Redemption Amount Until Forth Anniversary TemporaryEquityRedemptionAmountUntilForthAnniversary	10000000
CY2017	neo	Temporary Equity Redemption Amount At Forth Anniversary Thereafter TemporaryEquityRedemptionAmountAtForthAnniversaryThereafter	5000000
CY2017	neo	Temporary Equity Redemption At Forth Anniversary Thereafter Increments Above Redemption Amounts TemporaryEquityRedemptionAtForthAnniversaryThereafterIncrementsAboveRedemptionAmounts	1000000
CY2015Q4	neo	Temporary Equity Ten Year Liquidation Value TemporaryEquityTenYearLiquidationValue	190800000
CY2015	neo	Temporary Equity Effective Interest Rate TemporaryEquityEffectiveInterestRate	0.1006
CY2016Q4	neo	Temporary Equity Ten Year Liquidation Value TemporaryEquityTenYearLiquidationValue	85900000
CY2016	neo	Temporary Equity Effective Interest Rate TemporaryEquityEffectiveInterestRate	0.1006
CY2017	neo	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	3000000
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-91000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	56000
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-8000
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	14000
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	39000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	101000
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-77000
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	31000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	157000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2739000
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1451000
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1866000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.011
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12282000
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12222000
CY2016Q4	neo	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTaxNoncurrent	144000
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	297000
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-281000
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-245000
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-115000
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2557000
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1732000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2111000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0378
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0343
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0441
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.1338
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0188
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.2917
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.1976
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.1337
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.1024
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.0026
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.8853
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0989
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0002
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0073
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.4949
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.7570
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2291
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.4823
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	170000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	340000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	943000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	759000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	84000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	84000
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	107000
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	66000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1342000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1264000
CY2017Q4	neo	Deferred Tax Liabilities Accumulated Depreciation Amortization DeferredTaxLiabilitiesAccumulatedDepreciationAmortization	21235000
CY2016Q4	neo	Deferred Tax Liabilities Accumulated Depreciation Amortization DeferredTaxLiabilitiesAccumulatedDepreciationAmortization	29852000
CY2017	us-gaap	Operating Loss Carryforwards Expiration Date OperatingLossCarryforwardsExpirationDate	2029-12-31
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2240800
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	18650000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6342526
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5136110
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5440222
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1670205
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.012
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.49
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.84
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	304237
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.54
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.51
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	2.26
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	2.23
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4012096
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1819000
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	492091
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12500
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5326505
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2617526
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2483519
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	324402
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2119498
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	565569
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	347513
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2103342
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.04
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.90
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.45
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.19
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.07
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.14
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.69
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.99
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.76
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.60
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.84
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.12
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.51
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.50
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4008478
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1584554
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4239185
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.09
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.26
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.20
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.38
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.29
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	6342526
CY2017	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y2M27D
CY2017Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	6.52
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2103342
CY2017	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y5M5D
CY2017Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	5.50
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	14900000
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	7100000
CY2017Q4	neo	Common Stock Closing Price CommonStockClosingPrice	8.86
CY2017Q4	neo	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber	2100000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2772000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15003000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2470000
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2170000
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4179000
CY2017Q3	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	2651000
CY2015	neo	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue	3347000
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3617000
CY2017	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04
CY2017Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	1.00
CY2017Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	714000
CY2017	neo	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue	4782000
CY2016	neo	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue	6493000
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2165000
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	871000
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	5056000
CY2017	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	108599
CY2016	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	98672
CY2015	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	73958
CY2010Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	450000
CY2010Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.50
CY2017	neo	Operating Leases Expiration Period OperatingLeasesExpirationPeriod	2022-12
CY2017	neo	Area Of Office Space AreaOfOfficeSpace	51000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3473000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2890000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2401000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	762000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	325000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	9851000
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4700000
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4200000
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1900000
CY2017	neo	Purchase Commitments Expiration Year PurchaseCommitmentsExpirationYear	2020
CY2017Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	942000
CY2017Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	838000
CY2017Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	378000
CY2017Q4	us-gaap	Purchase Obligation PurchaseObligation	2158000
CY2017	neo	Capital Lease Expiration Year CapitalLeaseExpirationYear	2020
CY2017Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0520
CY2017	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	2500000
CY2017	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.75
CY2017Q1	neo	Defined Contribution Plan Employer Matching Additional Contribution Upon Employee Percent DefinedContributionPlanEmployerMatchingAdditionalContributionUponEmployeePercent	0.50
CY2017Q1	neo	Defined Contribution Plan Additional Maximum Annual Contributions Per Employee Percent DefinedContributionPlanAdditionalMaximumAnnualContributionsPerEmployeePercent	0.02
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2470000
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1660000
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	493000
CY2016	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2017Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	61676000
CY2017Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	66090000
CY2017Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	63052000
CY2017Q4	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	67792000
CY2017Q1	us-gaap	Gross Profit GrossProfit	27196000
CY2017Q2	us-gaap	Gross Profit GrossProfit	31178000
CY2017Q3	us-gaap	Gross Profit GrossProfit	28810000
CY2017Q4	us-gaap	Gross Profit GrossProfit	33132000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-654000
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-43000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-5100000
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	4951000
CY2017Q1	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	2566000
CY2017Q2	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	2639000
CY2017	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	10547000
CY2017Q4	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	2691000
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3220000
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2682000
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7751000
CY2017Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2260000
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.04
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2016Q2	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	5567000
CY2016Q3	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	5567000
CY2016Q4	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	7973000
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.03
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.04
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.03
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78650000
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79413000
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79617000
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86676000
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78650000
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79413000
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79617000
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88611000
CY2016Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	59704000
CY2016Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	63129000
CY2016Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	60761000
CY2016Q4	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	60489000
CY2016Q1	us-gaap	Gross Profit GrossProfit	27173000
CY2016Q2	us-gaap	Gross Profit GrossProfit	28605000
CY2016Q3	us-gaap	Gross Profit GrossProfit	27345000
CY2016Q4	us-gaap	Gross Profit GrossProfit	27256000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	155000
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	413000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-67000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-6224000
CY2016Q1	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	5567000
CY2016	neo	Redeemable Preferred Stock Dividends And Amortization Of Preferred Stock Beneficial Conversion Feature RedeemablePreferredStockDividendsAndAmortizationOfPreferredStockBeneficialConversionFeature	24674000
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5412000
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5154000
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5634000
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14197000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.18
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.07
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.07
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.07
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.18
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76068000
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77448000
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78145000
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78490000
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76068000
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77448000
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78145000
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78490000

Files In Submission

Name	View Source	Status
0001564590-18-005479-index-headers.html	Edgar Link	pending
0001564590-18-005479-index.html	Edgar Link	pending
0001564590-18-005479.txt	Edgar Link	pending
0001564590-18-005479-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g201803131756431605448.jpg	Edgar Link	pending
neo-10k_20171231.htm	Edgar Link	pending
neo-20171231.xml	Edgar Link	completed
neo-20171231.xsd	Edgar Link	pending
neo-20171231_cal.xml	Edgar Link	unprocessable
neo-20171231_def.xml	Edgar Link	unprocessable
neo-20171231_lab.xml	Edgar Link	unprocessable
neo-20171231_pre.xml	Edgar Link	unprocessable
neo-ex211_8.htm	Edgar Link	pending
neo-ex231_11.htm	Edgar Link	pending
neo-ex311_6.htm	Edgar Link	pending
neo-ex312_10.htm	Edgar Link	pending
neo-ex321_7.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEO
NEOGENOMICS INC Stock $neo

2017 Q4 Form 10-K Financial Statement

#000156459018005479 Filed on March 13, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEO NEOGENOMICS INC Stock $neo

2017 Q4 Form 10-K Financial Statement

#000156459018005479 Filed on March 13, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEO
NEOGENOMICS INC Stock $neo